
David Michael
Managing Partner
Co-founder investing in industrial technology and life sciences tools, with financing and company-building experience.
United States / Direct investor

Turning breakthrough technology into businesses.
Investing in industrial, clean technology and life sciences companies, with hands-on support from scientific and operating teams.
Connect Now01 / The firm
Anzu Partners focuses on companies built around breakthrough technology, from advanced materials, energy storage and semiconductor hardware to biological tools, medical devices and medicines. Its investment platform spans venture capital, private credit and public-market structures.
The firm describes approximately $1 billion managed across these strategies. Its Longview Innovation platform also works with university and national-laboratory technologies to form and build companies.
Official firm overview ↗ · Longview platform & headquarters ↗ · Fund on X ↗02 / Portfolio
All 56 relationships in Anzu's current directory are retained, including historical companies and exits. These are not 56 independent active holdings: BioFlyte and Zeteo Tech have recombined as Spectara; ExOne and voxeljet now share a holding company. General software, services and other holdings remain under Others.

Developed blood-based biomarkers that help assess traumatic brain injury.

Developed airborne biological-threat detection; it has recombined with Zeteo Tech as Spectara.

Develops methods that copy genetic material from individual cells so researchers can measure it more completely.

Developed therapies that engineer macrophages, immune cells that engulf targets, to attack tumors.

Develops tools that measure proteins, DNA and RNA together to support biological research.

Uses computational protein design and laboratory testing to discover and improve therapeutic proteins.

Developed electronic plates with tiny sensors that monitor living cells for drug research.

Makes tiny structures in plastic for diagnostic tests, laboratory devices and medical applications.

Develops gene-editing therapies intended to remove or disable viral DNA in infected cells.

Profiles immune cells and develops cell therapies aimed at solid tumors.

Combines measurements of sugar-linked proteins with computation to develop disease biomarkers.

Builds instruments that separate complex mixtures of molecules before analysis to support biological research.

Developed microfluidic instruments that gently select and sort individual cells.

Develops optical instruments that measure the contents of bioprocess fluids to help control medicine production.

Develops cell-free methods for manufacturing RNA and proteins without growing intact production cells.

Develops small engineered carriers that deliver RNA, DNA and other medicines to selected cells and tissues.

Develops silk-protein biomaterials for medical implants and tissue restoration.

Develops aerosol collection and analysis systems for detecting biological threats and infectious disease.

Developed biological-threat detection technology; it has recombined with its BioFlyte spinout as Spectara.

Uses microwave plasma, an electrically heated gas, to make battery materials and metal powders.

Turns metal scrap into powders for industrial 3D printing using microwave plasma processing.

Developed slippery coatings that repel fluids and contamination for industrial, marine and medical uses.
Links to the fund profile; no verified current company website.

Develops a dry process for making battery electrodes without the solvent-recovery and drying steps of conventional production.

Makes industrial 3D printers that bind powders into sand molds, cores and manufactured parts.

Develops zinc-based energy storage designed to hold electricity for long periods.

Develops permanent magnets based on iron and nitrogen rather than rare-earth elements.

Develops advanced materials and computational methods for organic light-emitting diode displays.

Develops liquefied-gas electrolytes intended to improve lithium-battery performance across demanding temperatures.

Makes large-format industrial 3D printers and printing services, including sand molds and cores.

Builds engineering software to design and operate microgrids with generation, batteries and other distributed energy equipment.

Develops closed-loop geothermal systems that extract underground heat for round-the-clock electricity.

Develops an investigational home device that measures blood phenylalanine for people with the metabolic disorder PKU. It is not FDA-cleared or approved.

Makes compact optical engines for medical imaging and industrial measurement.

Develops implanted hearing devices, including an investigational fully implanted cochlear implant.

Builds autonomous robotic systems that map mines and other complex places without GPS.

Uses soft optical sensors to measure surface details and give robots a sense of touch.

Makes programmable electronic test instruments that combine measurement and signal processing in one device.

Develops high-power blue lasers for industrial metal processing, including welding and additive manufacturing.

Designs low-power analog chips that identify useful sensor signals before waking a device's main processor.

Develops thin light-guiding technology for sunlight-readable, low-power electronic displays.

Develops miniature magnetic components for power conversion in advanced computing hardware.

Develops chips that perform AI calculations within memory to reduce the movement of data and power use.

Develops wafer-level micro-LED displays for bright, compact wearable and industrial products.

Makes gas-flow monitoring and control equipment used in semiconductor manufacturing.

Develops wafer-scale optical components and computational imaging for compact cameras.

Developed physics-based software that optimizes material use and manufacturing parameters for 3D-printed parts.

Developed simulation software that predicts how advanced materials behave and fail before physical testing.

Builds AI-driven engineering tools that run design, physics simulation and analysis workflows for hardware teams.

Provides live captioning, transcription and translation using speech-recognition software and human services.

Makes open-source electronics boards and software used to prototype connected devices and hardware products.

Makes modular laptops and computers designed for repair, upgrades and reuse.

Provides business internet, voice, networking and cloud connectivity services.

Now operates as OpsReady, providing software that organizes industrial work, field data and operations.

Provides cybersecurity software and regulatory support for makers of medical devices.

Provides image and text search software that helps industrial teams identify and find spare parts.

Provides data-analysis software that helps battery teams monitor development, manufacturing yield and performance.
03 / Team & connect

Managing Partner
Co-founder investing in industrial technology and life sciences tools, with financing and company-building experience.

Managing Partner
Co-founder and professional investor leading transactions and portfolio-company support.

Managing Partner
Co-founder leading private credit, software, medical-device and structured public-equity investments.

Partner
Investment partner focused on semiconductors, hardware and next-generation materials.

Partner
Professional investor and transaction advisor; the firm appointed him to its investment committee and strategic transactions remit.

Partner
Longview Innovation founder and investor in early-stage university and national-laboratory technologies.

Partner
Longview Innovation investor and company builder, supporting the development and commercialization of healthcare technologies.

Principal, Investment
Leads investment diligence and sourcing in chemicals, materials and life sciences, alongside portfolio commercialization work.

Principal, Investment
Sources and evaluates materials, electrification and manufacturing investments and supports portfolio companies.
Investment Director
Conducts investment diligence and sources industrial materials and climate technologies.

Principal, Investment
Principal, Investment, managing energy-transition investments and the sourcing pipeline, according to his official biography.
Josh Stiling's current biography and promotion announcement identify him as Principal, Investment; an older grid entry still says Investment Director. Michael Burychka and Jason Smith joined through the Longview platform. Debrah Herman's Partner role is Chief Financial Officer, so she is not presented as an investment contact.
Josh promotion ↗ · Longview integration ↗For investment enquiries, use the firm's general inbox. Individual email addresses are not inferred from name patterns. The media inbox is not an investment contact.